Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression.
Fava VAR, Sarin LM, Lucchese AC, Del Sant L, Magalhães E, Delfino RS, Tuena MA, Nakahira C, Jackowski AP, Abdo G, Surjan J, Steiglich M, Barbosa MG, Porto JAD, Lacerda ALT, Cogo-Moreira H. Fava VAR, et al. Among authors: sarin lm. Rev Psiquiatr Salud Ment (Engl Ed). 2021 Oct-Dec;14(4):212-217. doi: 10.1016/j.rpsmen.2021.11.003. Rev Psiquiatr Salud Ment (Engl Ed). 2021. PMID: 34861929
A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression.
Magalhães EJM, Sarin LM, Del Sant LC, Lucchese AC, Nakahira C, Tuena MA, Puertas CB, Rodovalho Fava VA, Delfino RS, Surjan J, Steglich MS, Barbosa MG, Abdo G, Del Porto JA, Nemeroff CB, Cogo-Moreira H, Lacerda ALT, Mello AF. Magalhães EJM, et al. Among authors: sarin lm. Front Psychiatry. 2021 Aug 17;12:608499. doi: 10.3389/fpsyt.2021.608499. eCollection 2021. Front Psychiatry. 2021. PMID: 34483976 Free PMC article.
Reply to Letter to the Editor.
Lucchese AC, Sarin LM, Muniz Magalhães EJ, Andreoli SB. Lucchese AC, et al. Among authors: sarin lm. J Psychopharmacol. 2021 Aug 3:2698811211035392. doi: 10.1177/02698811211035392. Online ahead of print. J Psychopharmacol. 2021. PMID: 34344207 No abstract available.
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity.
Lucchese AC, Sarin LM, Magalhães EJM, Del Sant LC, B Puertas C, Tuena MA, Nakahira C, Fava VA, Delfino R, Surjan J, Steiglich MS, Barbosa M, Abdo G, Cohrs FM, Liberatori A, Del Porto JA, Lacerda AL, B Andreoli S. Lucchese AC, et al. Among authors: sarin lm. J Psychopharmacol. 2021 Feb;35(2):142-149. doi: 10.1177/0269881120978398. Epub 2021 Jan 9. J Psychopharmacol. 2021. PMID: 33427015
The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression.
Fava VAR, Sarin LM, Lucchese AC, Del Sant L, Magalhães E, Delfino RS, Tuena MA, Nakahira C, Jackowski AP, Abdo G, Surjan J, Steiglich M, Barbosa MG, Porto JAD, Lacerda ALT, Cogo-Moreira H. Fava VAR, et al. Among authors: sarin lm. Rev Psiquiatr Salud Ment (Engl Ed). 2020 Oct 16:S1888-9891(20)30117-8. doi: 10.1016/j.rpsm.2020.10.003. Online ahead of print. Rev Psiquiatr Salud Ment (Engl Ed). 2020. PMID: 33075541 English, Spanish.
Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression.
Del Sant LC, Sarin LM, Magalhães EJM, Lucchese AC, Tuena MA, Nakahira C, Fava VAR, Delfino R, Surjan J, Steiglich MS, Barbosa M, Abdo G, Cohrs FM, Liberatori A, Del Porto JA, Lacerda ALT, de Jesus Mari J. Del Sant LC, et al. Among authors: sarin lm. J Psychopharmacol. 2020 Oct;34(10):1155-1162. doi: 10.1177/0269881120922955. Epub 2020 Jul 8. J Psychopharmacol. 2020. PMID: 32638662
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.
Correia-Melo FS, Leal GC, Vieira F, Jesus-Nunes AP, Mello RP, Magnavita G, Caliman-Fontes AT, Echegaray MVF, Bandeira ID, Silva SS, Cavalcanti DE, Araújo-de-Freitas L, Sarin LM, Tuena MA, Nakahira C, Sampaio AS, Del-Porto JA, Turecki G, Loo C, Lacerda ALT, Quarantini LC. Correia-Melo FS, et al. Among authors: sarin lm. J Affect Disord. 2020 Mar 1;264:527-534. doi: 10.1016/j.jad.2019.11.086. Epub 2019 Nov 14. J Affect Disord. 2020. PMID: 31786030 Clinical Trial.
11 results